Yield10 Bioscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Yield10 Bioscience generated cash of -$10,068,000, which is more than the previous year. Cash used in financing activities reached the amount of $6,871,000 last year. Net change in cash is therefore -$1,288,000.
Cash Flow
| 2014 | -24.24M | 11.38M | 25.21M |
|---|---|---|---|
| 2015 | -21.86M | -614K | 14.70M |
| 2016 | -14.7M | 9.75M | 85K |
| 2017 | -8.20M | 109K | 15.27M |
| 2018 | -8.75M | -2.78M | 118K |
| 2019 | -8.65M | -3.01M | 14.07M |
| 2020 | -8.65M | -645K | 7.27M |
| 2021 | -9.25M | -4.57M | 15.74M |
| 2022 | -11.40M | 8.52M | -37K |
| 2023 | -10.06M | 1.94M | 6.87M |
YTEN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.62M | 5.59M | 3.68M | 5.74M | 3.35M | 14.80M | 7.30M | 12.26M | 20.04M | 7.69M |
Operating activities | ||||||||||
Net income | -14.45M | -13.56M | -11.03M | -10.20M | -12.95M | -9.18M | -9.39M | -7.60M | -23.68M | -26.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 290K | 263K | 220K | 182K | 203K | 196K | 206K | 515K | 265K | 507K |
Stock-based compensation expense | 1.59M | 1.90M | 1.67M | 739K | 656K | 0 | 1.39M | 848K | 2.12M | 2.27M |
| Deferred income tax benefit | 1.59M | 1.90M | 1.67M | 739K | 656K | 0 | 1.39M | 848K | 2.12M | 2.27M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 30K | 164K | -78K | -14K | 22K | -40K | 12K | 172K | -193K | 952K |
Inventories | 0 | 0 | 0 | -578K | 0 | -994K | 95K | 180K | -2K | 462K |
Accounts payable | 1.09M | 26K | 23K | -219K | 162K | 41K | 17K | -51K | -226K | -246K |
Cash generated by operating activities | -10.06M | -11.40M | -9.25M | -8.65M | -8.65M | -8.75M | -8.20M | -14.7M | -21.86M | -24.24M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -2.44M | -10.63M | -9.27M | -5.70M | -11.49M | 0 | 0 | 0 | -1.50M |
Investments In Property Plant And Equipment | -46K | -154K | -189K | -76K | -61K | -42K | -6K | -752K | -654K | -172K |
Acquisitions Net | 0 | -8.67M | 4.38M | 10K | 2.95M | 0 | 0 | 10.31M | 40K | -292K |
Cash generated by investing activities | 1.94M | 8.52M | -4.57M | -645K | -3.01M | -2.78M | 109K | 9.75M | -614K | 11.38M |
Financing activities | ||||||||||
Common Stock Issued | 103K | 0 | 15.84M | 5.30M | 14.08M | 0 | 15.28M | 85K | 14.70M | 24.91M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -1.42M | 0 | 0 | 0 |
Repurchases of common stock | 0 | -37K | -103K | -17K | 0 | -6K | 0 | -296K | 0 | 0 |
Repayments of term debt | 967K | 0 | 0 | -333K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 6.87M | -37K | 15.74M | 7.27M | 14.07M | 118K | 15.27M | 85K | 14.70M | 25.21M |
Net Change In Cash | -1.28M | -2.97M | 1.90M | -2.06M | 2.39M | -11.44M | 7.17M | -4.96M | -7.77M | 12.34M |
Cash at end of period | 1.33M | 2.62M | 5.59M | 3.68M | 5.74M | 3.35M | 14.48M | 7.30M | 12.26M | 20.04M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |